Literature DB >> 24344037

The prevalence of usage of herbal medicines among cancer patients.

S Tuna1, O Dizdar, M Calis.   

Abstract

PURPOSE: To study the prevalence of the usage of herbal medicines among cancer patients.
METHODS: This study was carried out between October 1, 2009 and May 31, 2011, by using face-to-face interviews with cancer patients attending oncology departments (clinics and outpatient clinics, chemotherapy units). A special questionnaire was filled in during the interviews.
RESULTS: Of the patients 68.2% reported usage of herbal medicines, 66% stated that their usage of herbal medicines was based on the media and the Internet as a source and 64% stated that they received information about herbal medicines from relatives and friends. Only 24% of herbal medicines users had consulted or discussed their use with a physician.
CONCLUSION: In Turkey, especially among cancer patients, there is a high prevalence of complementary and alternative medicine (CAM) usage and the most commonly used form of CAM is herbal medicines. This prevalence has also been found to be high in our research as well. Due to the probable side effects and potential drug interactions of herbal agents, all cancer patients should be asked about their use of herbal medicines.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24344037

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


  9 in total

Review 1.  Identifying Complementary and Alternative Medicine Usage Information from Internet Resources. A Systematic Review.

Authors:  Vivekanand Sharma; John H Holmes; Indra N Sarkar
Journal:  Methods Inf Med       Date:  2016-06-28       Impact factor: 2.176

2.  Investigation into Complementary and Integrative Health Approaches for Turkish Patients with Gastrointestinal Cancer.

Authors:  Seda Pehlivan; Ali Süner; Yasemin Yıldırım; Çiçek Fadıloğlu
Journal:  J Relig Health       Date:  2018-08

3.  Role of clinical pharmacists to prevent drug interactions in cancer outpatients: a single-centre experience.

Authors:  Carmen Lopez-Martin; Margarita Garrido Siles; Julia Alcaide-Garcia; Vicente Faus Felipe
Journal:  Int J Clin Pharm       Date:  2014-10-19

4.  Complementary and alternative medicine in cancer patients: characteristics of use and interactions with antineoplastic agents.

Authors:  Vicente Escudero-Vilaplana; Roberto Collado-Borrell; Patricia Gómez Martínez-Sagrera; Cristina Villanueva-Bueno; José Luis Revuelta-Herrero; Eva Gonzalez-Haba; Ángela Hoyo-Muñoz; Yolanda Jerez Gilarranz; Belén Marzal-Alfaro; Ana Herranz; Miguel Martin; María Sanjurjo
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-06       Impact factor: 4.553

5.  Orally consumed ginger and human health: an umbrella review.

Authors:  Megan Crichton; Alexandra R Davidson; Celia Innerarity; Wolfgang Marx; Anna Lohning; Elizabeth Isenring; Skye Marshall
Journal:  Am J Clin Nutr       Date:  2022-06-07       Impact factor: 8.472

6.  Use of Medicinal Plants by Cancer Patients Under Chemotherapy in the Northwest of Morocco (Rabat Area) : Cross-Sectional Study.

Authors:  Nadia El Orfi; Saber Boutayeb; Bouchra Haddou Rahou; Hassan Errihani
Journal:  J Evid Based Integr Med       Date:  2022 Jan-Dec

7.  An assessment of the impact of herb-drug combinations used by cancer patients.

Authors:  Saud M Alsanad; Rachel L Howard; Elizabeth M Williamson
Journal:  BMC Complement Altern Med       Date:  2016-10-18       Impact factor: 3.659

8.  Real-life drug-drug and herb-drug interactions in outpatients taking oral anticancer drugs: comparison with databases.

Authors:  F Ranchon; C Rioufol; H Prely; C Herledan; A G Caffin; A Baudouin; V Larbre; M Maire; V Schwiertz; N Vantard
Journal:  J Cancer Res Clin Oncol       Date:  2021-04-29       Impact factor: 4.553

9.  Use of medicinal plants by cancer patients at the National Institute of Oncology, Rabat: a cross-sectional survey.

Authors:  Nadia El Orfi; Saber Boutayeb; Bouchra Haddou Rahou; Ahlam Aitouma; Amine Souadka
Journal:  Pan Afr Med J       Date:  2021-09-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.